Jim Tananbaum is the founder and CEO of Foresite Capital. He set up the organization in 2011 as a private equity company. He is a very experienced venture capitalist who has helped many emerging healthcare leaders to achieve their dreams by offering them capital, networks, and relevant information. In addition, Jim has also played a critical role in the formation of other companies that deal with the production of biopharmaceutical products and healthcare investment practices, reveals businesswire.com.
Throughout his professional career, Jim Tananbaum has always played a key role in the formation capital ventures as a consultant and partner. He came up with Foresite Capital using the vast experience and knowledge from his eventful career. His dream has always been to assist emerging leaders in healthcare innovation by creating sustainable investment platform for them. Jim uses interdisciplinary collaborations and his knowledge in computer science to come up with solutions for various healthcare problems. Learn more about Foresite Capital on insidermonkey.com.
About Jim Tananbaum
Jim is has a background in computer science and electrical engineering. He attended medical and business schools at Harvard University. He is also a graduate of the Massachusetts Institute of Technology where he acquires an MS degree. He established Gel Tex Pharmaceuticals after leading college. Jim has over the years been mentored by leading academicians in different fields. He has been a leading healthcare entrepreneur and investment strategist for more than 25 years. Jim largely focuses on helping emerging entrepreneurs with an aim of helping them to come up with innovative healthcare products and solutions by investing time and money.
According to pelotontherapeutics.com, through his firm Foresight Capital, he has been able to invest in over 77 healthcare firms that deal with diagnostics, biopharmaceutical products, medical services, and genomic sequencing. Before establishing Foresight Capital, he was also involved in the formation two healthcare investment practices as well as two healthcare investment practices. Jim has also led numerous investments in Jazz Pharmaceuticals, Healtheon, Amerigroup, Prospect Venture Partners, and Amira Pharmaceuticals. He has also served on the advisory boards on Yale’s Advisory Council and the Harvard-MIT HST program. Jim has a very impressive record in building franchise healthcare businesses by offering both financial and operational opportunities.